Your shopping cart is currently empty

KUS121 is a valosin-containing protein modulator that inhibits VCP ATPase activity with an IC50 of 330 nM, suppresses tunicamycin-induced ATP depletion, cell death, and CHOP upregulation in HeLa cells, protects primary cortical neurons from oxygen-glucose deprivation injury in vitro, reduces infarct volume and improves motor performance in mouse models of focal cerebral ischemia, and preserves retinal structure and visual function in rd10 retinitis pigmentosa models, supporting its investigation in neuroprotection and ischemic disease research.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $63 | 35 days | 35 days | |
| 5 mg | Preferential | - | In Stock |
| Description | KUS121 is a valosin-containing protein modulator that inhibits VCP ATPase activity with an IC50 of 330 nM, suppresses tunicamycin-induced ATP depletion, cell death, and CHOP upregulation in HeLa cells, protects primary cortical neurons from oxygen-glucose deprivation injury in vitro, reduces infarct volume and improves motor performance in mouse models of focal cerebral ischemia, and preserves retinal structure and visual function in rd10 retinitis pigmentosa models, supporting its investigation in neuroprotection and ischemic disease research. |
| In vivo | In animal models of ischemic retinal injury, intravitreal (IVT) injection of KUS121 (25 ug/eye) mitigates retinal damage. The administration is associated with the suppression of inner retinal layer thinning at 7 and 14 days post-injury, preserving retinal morphology and visual function. In rd10 mice (a model for retinitis pigmentosa), KUS121 inhibits the thinning of the outer nuclear layer and maintains visual acuity. These in vivo effects are linked to the suppression of Endoplasmic Reticulum (ER) stress, characterized by reduced expression of the marker CHOP, activation of the mTOR signaling pathway, and inhibition of apoptosis [1][2][3][4]. |
| Synonyms | KUS-121, KUS 121 |
| Molecular Weight | 458.44 |
| Formula | C22H16FN4NaO3S |
| Cas No. | 1357164-52-3 |
| Smiles | O=S([O-])(C1=CC(N=NC2=CN=C(C3=C(C)C=C(F)C=C3)C=C2)=C(C4=C1C=CC=C4)N)=O.[Na+] |
| Storage | store at low temperature | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 48 mg/mL (104.7 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.